Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

CEFTRIAXONE SODIUM FOR INJECTION BP

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is CEFTRIAXONE SODIUM FOR INJECTION BP discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that CEFTRIAXONE SODIUM FOR INJECTION BP 250MG has been permanently discontinued (last updated October 27, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is CEFTRIAXONE SODIUM FOR INJECTION BP not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file3 products · 2 same form & route
Affected strength250MG
Report last updated2026-10-27
Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

CEFTRIAXONE SODIUM FOR INJECTION BP

STERIMAX INC

1G · DIN 02325616

Different strengthSame dosage formSame routeNo current shortage

CEFTRIAXONE FOR INJECTION

FRESENIUS KABI CANADA LTD

100G · DIN 02409968

Different strengthSame dosage formSame routeNo current shortage

CEFTRIAXONE INJECTION, USP

BAXTER CORPORATION

2000MG · DIN 02499738

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02325594

Strength

250MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

CEFTRIAXONE

See all CEFTRIAXONE products →

Shortage History